GENFIT (EPA:GNFT) | Finanzwire

Basculer en Français

8235	Companies
111177	Keywords
52887	Articles
61025	Press releases

Home
Companies
GENFIT

BRIEF

published on 11/07/2024 at 22:15, 2 days 8 hours ago

GENFIT Reports Third Quarter 2024 Financial Update

Revenue Growth PBC Treatment GENFIT Financials Cash Position 2024 Ipsen Collaboration
PRESS RELEASE

published on 11/07/2024 at 22:10, 2 days 8 hours ago

GENFIT Reports Third Quarter 2024 Financial Information
GENFIT reports €59.7M revenue for Q3 2024 with €96.0M cash. Focus on liver diseases. Results surpass 2023

Revenue Cash Position Q3 2024 Liver Diseases GENFIT
PRESS RELEASE

published on 09/19/2024 at 22:10, 1 month 20 days ago

GENFIT Reports First Half-Year 2024 Financial Results and Provides Corporate Update
BRIEF

published on 07/26/2024 at 13:50, 3 months 14 days ago

GENFIT: Positive Opinion from EMA Committee for Ipsen’s Iqirvo® in Primary Biliary Cholangitis

GENFIT EMA Iqirvo® Elafibranor PBC Treatment
PRESS RELEASE

published on 07/26/2024 at 13:45, 3 months 14 days ago

GENFIT: Positive Opinion from EMA Committee for Ipsen’s Iqirvo® (elafibranor) in Primary Biliary Cholangitis
GENFIT receives positive opinion from EMA Committee for Ipsen’s Iqirvo® (elafibranor) in Primary Biliary Cholangitis, awaiting final European Commission decision. Details in press release

GENFIT PBC Treatment Positive Opinion EMA Committee Ipsen's Iqirvo
BRIEF

published on 07/09/2024 at 22:15, 4 months ago

GENFIT Announces Half-Year Liquidity Contract Report with Crédit Industriel et Commercial

Liquidity Contract Shares Biopharmaceutical GENFIT Trading Report
PRESS RELEASE

published on 07/09/2024 at 22:10, 4 months ago

GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial
GENFIT announces half-year report of liquidity contract with Crédit Industriel et Commercial, revealing trading details and resources as of June 30, 2024

Liquidity Contract Crédit Industriel Et Commercial GENFIT Resources Trading Details
BRIEF

published on 06/17/2024 at 22:15, 4 months 22 days ago

GENFIT: NIS2+® Included in New Clinical Guidelines for MASLD

GENFIT MASH NIS2+® MASLD Clinical Guidelines
PRESS RELEASE

published on 06/17/2024 at 22:10, 4 months 22 days ago

GENFIT: New EASL-EASD-EASO Clinical Practice Guidelines for MASLD Include NIS2+® as Key Tool for Detecting At-Risk MASH
GENFIT announces inclusion of NIS2+® in new EASL-EASD-EASO Clinical Practice Guidelines for MASLD, as a key tool for detecting at-risk MASH. Guidelines provide update on prevention, screening, diagnosis, follow-up, and treatment for MASLD

GENFIT MASH NIS2+® MASLD EASL-EASD-EASO
BRIEF

published on 06/10/2024 at 23:27, 4 months 29 days ago

GENFIT: Accelerated approval of Iqirvo® by the FDA for Primary Biliary Cholangitis

FDA Biopharmaceutical Primary Biliary Cholangitis GENFIT Iqirvo

Accesswire

Published on 11/10/2024 at 02:00, 4 hours 42 minutes ago

Spey Resources Corp. enters into Share Exchange Agreement with Antimony Assets and announces Name Change
Published on 11/09/2024 at 16:30, 14 hours 12 minutes ago

New to the Street Premieres Episode 611 on Bloomberg Television Tonight at 6:30 PM EST, Featuring Zapp Electric Vehicles, OriginClea and PillSafe
Published on 11/09/2024 at 04:00, 1 day 2 hours ago

Freedom Holding Corp. Reports Second Quarter Fiscal Year 2025 Financial Results
Published on 11/08/2024 at 23:05, 1 day 7 hours ago

Murchison Minerals Announces Non-Brokered Private Placement
Published on 11/08/2024 at 22:30, 1 day 8 hours ago

Justera Health Announces RSU Grant

View all ACCESSWIRE

EQS Group

Published on 11/08/2024 at 18:35, 1 day 12 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/08/2024 at 18:20, 1 day 12 hours ago

ENCAVIS achieves results in the first three quarters of 2024 below the figures for the same period of the previous year due to unforeseeable events and adjusts guidance for the current financial year
Published on 11/08/2024 at 18:15, 1 day 12 hours ago

EQS-Adhoc: ENCAVIS AG
Published on 11/08/2024 at 18:02, 1 day 12 hours ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/08/2024 at 18:00, 1 day 12 hours ago

2CRSi SA: Provision of the Financial Report

Les Echos

Published on 11/08/2024 at 18:00, 1 day 12 hours ago

Covivio - Information on total number of voting rights and share capital
Published on 11/08/2024 at 17:52, 1 day 12 hours ago

Total number of voting rights and shares making up the share capital at October 31, 2024
Published on 11/08/2024 at 17:45, 1 day 12 hours ago

CHARGEURS - Voting rights monthly statement as of October 31st, 2024
Published on 11/08/2024 at 17:35, 1 day 13 hours ago

Disclosure of the number of shares and the total number of voting rights as of October 31, 2024
Published on 11/08/2024 at 12:32, 1 day 18 hours ago

Louis Hachette Group announces the publication of its Information Document for listing on Euronext Growth (Paris)

View all LES ECHOS COMFI WIRE